5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as CXC-chemokine receptor ligands
US7897606B2 · kind B2 · utility
0Cited by
14References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 27, 2006 |
| Grant date | Mar 1, 2011 |
| Priority date | — |
| Expiry date | Nov 2, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds of the formulaand the pharmaceutically acceptable salts thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.